Saquinavir: Difference between revisions
imported>David E. Volk (Chem infobox) |
imported>David E. Volk No edit summary |
||
Line 10: | Line 10: | ||
|molformula= C<sub>38</sub>H<sub>5</sub>0N<sub>6</sub>O<sub>5</sub> | |molformula= C<sub>38</sub>H<sub>5</sub>0N<sub>6</sub>O<sub>5</sub> | ||
|molmass= 670.8408 | |molmass= 670.8408 | ||
|uses=HIV | |uses= HIV | ||
|properties=protease inhibitor | |properties=protease inhibitor | ||
|hazards=see drug interactions | |hazards=see drug interactions |
Revision as of 08:44, 22 March 2008
| |||||||
saquinavir | |||||||
| |||||||
Uses: | HIV | ||||||
Properties: | protease inhibitor | ||||||
Hazards: | see drug interactions | ||||||
|
Saquinavir, abbreviated SQV and sold under the trade names Fortovase®, Invirase® and ROC®, is a protease inhibitor used to treate HIV/AIDS. It is effective againsts HIV-1 and HIV-2. Saquinavir binds to the protease active site and inhibits its activity, thus preventing cleavage of the viral polyproteins resulting in immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs and due to their short half-life, often must be taken about every four hours.
Chemistry
Its IUPAC chemical name is (2S)-N-[(2S,3R)-4-[(3S)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide and its chemical formula is C38H50N6O5.
External links
- Saquinavir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank